Search results for "Prostate Cancer"
MKSAP Quiz: Exacerbations of heart failure
A 68-year-old man is evaluated at a follow-up appointment. He has a 7-year history of heart failure secondary to ischemic cardiomyopathy. Over the past 6 months, he has had three hospitalizations for exacerbations of his heart failure. He currently has exertional dyspnea while getting dressed, and his maximal activity level is limited to riding to the store with his wife but staying in the car. Following a physical exam and lab studies, what is the most appropriate management?
https://immattersacp.org/weekly/archives/2018/03/13/3.htm
13 Mar 2018
Leflunomide gets boxed warning, ARBs under review
Recalls, warnings, approvals and other regulatory news.
https://immattersacp.org/archives/2010/09/fda.htm
1 Sep 2010
Aiding patients' decisions on PSA screening
Routine prostate-specific antigen (PSA) screening of all men over a certain age began about 20 years ago, but the certainty about whether that was or is wise medical practice is long gone.
https://immattersacp.org/archives/2011/07/prostate.htm
1 Jul 2011
Evidence lacking for routine prostate screening, but single test at 60 may help
Exacerbation-susceptible subtype may exist in COPD
https://immattersacp.org/weekly/archives/2010/09/21/4.htm
21 Sep 2010
Annual PSA follow-ups not needed in low-risk cases
Medicare expands tobacco cessation coverage
https://immattersacp.org/weekly/archives/2010/08/31/5.htm
31 Aug 2010
‘Smart’ drugs could be bad idea
This issue covers performance-enhancing drugs, prostate cancer options, and transgender health.
https://immattersacp.org/archives/2017/11/smart-drugs-could-be-bad-idea.htm
1 Nov 2017
Antidepressant may help cognitive recovery after stroke
Internists should follow up with prostate cancer patients receiving ADT
https://immattersacp.org/weekly/archives/2010/02/09/4.htm
9 Feb 2010
Communication skills vital to cancer conversations
Cancer patients want information, but not in a way that makes them lose hope. Effective shared decision making and risk communication strategies can help.
https://immattersacp.org/archives/2013/09/communication.htm
1 Sep 2013
Tailor prostate screening based on life expectancy, ASCO recommends
A provisional clinical opinion from the American Society of Clinical Oncology (ASCO) recommends against prostate-specific antigen screening for men with a life expectancy of 10 years or less.
https://immattersacp.org/weekly/archives/2012/07/24/2.htm
24 Jul 2012
Propoxyphene withdrawn, bevacizumab loses indication
Recalls, warnings, and approvals.
https://immattersacp.org/archives/2011/02/fda.htm
1 Feb 2011